Mechanisms of HIV Latency: an Emerging Picture of Complexity
- 722 Downloads
Rarely HIV type 1 establishes proviral latency within the host genome, maintained with little or no viral gene expression. This state has been quantitated in peripheral blood and lymphoid tissues of HIV-infected patients, appearing in the earliest days of infection. These rare cellular reservoirs are unaffected by current antiretroviral therapy and unrecognized by the host immune response, and can regenerate disseminated viremia if therapy is interrupted. Proviral latency may be established when a newly HIV-infected cell exits the cell cycle and returns to the resting state. Rarely, direct infection of resting cells may also occur. Multiple molecular mechanisms appear to underlie the establishment and maintenance of persistent, latent HIV infection, most frequent in the resting central memory CD4+ T cell. Interrupting processes that maintain latency may allow therapeutic attack of this primary form of persistent HIV infection, but a better understanding of relevant mechanisms in vivo is needed.
KeywordsLatency Resting CD4+ T cell Chromatin Histone HDAC Methylation IL-7
Dr. Margolis has received research support from Merck Research Laboratories, who produce Vorinostat (suberoylanilide hydroxamic acid).
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
- 24.• Keedy KS, Archin NM, Gates AT, et al.: A limited group of class I histone deacetylases acts to repress human immunodeficiency virus type 1 expression. J Virol 2009, 83:4749–4756.Google Scholar
- 25.• Archin NM, Keedy KS, Espeseth A, et al.: Expression of latent human immunodeficiency virus type 1 is induced by novel and selective histone deacetylase inhibitors. AIDS 2009, 23:1799–1806. Together, Keedy et al. [24•] and Archin et al. [25•] demonstrate the promise of targeting HDACs by selective HDACi, toward the goal of depletion of resting CD4+ T-cell infection.Google Scholar
- 28.• Pearson R, Kim YK, Hokello J, et al.: Epigenetic silencing of human immunodeficiency virus (HIV) transcription by formation of restrictive chromatin structures at the viral long terminal repeat drives the progressive entry of HIV into latency. J Virol 2008, 82:12291–12303. This work elegantly illustrates the concept of layers of regulation that obstruct HIV promoter that must be overcome by sufficient signaling.Google Scholar
- 29.• Blazkova J, Trejbalova K, Gondois-Rey F, et al.: CpG methylation controls reactivation of HIV from latency. PLoS Pathog 2009, 5:e1000554.Google Scholar
- 30.• Kauder SE, Bosque A, Lindqvist A, et al.: Epigenetic regulation of HIV-1 latency by cytosine methylation. PLoS Pathog 2009, 5:e1000495. Blazkova et al. [29•] and Kauder et al. [30•] together illustrate the potential importance of DNA methylation as an additional restriction to HIV expression. Their work suggests that therapeutic interventions must also target this restriction in order to affect the full complement of quiescent proviral genomes within the resting CD4 cell reservoir.Google Scholar
- 31.•• Chomont N, El-Far M, Ancuta P, et al.: HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation. Nat Med 2009, 15:893–900. This work highlights the possibility that proviral genomes within the central memory pool of infected memory CD4+ T cells are subject to expansion by the normal process of cell homeostasis. The authors pose the daunting hypothesis that the novel approach of inhibiting homeostatic expansion of the memory cell pool may be necessary to eradicate latent infection.Google Scholar